Yes, Trichophyton rubrum is highly susceptible to oral terbinafine, and this should be your first-line treatment for this patient's nail infection that failed topical therapy.
Organism Susceptibility
Terbinafine has broad and potent fungicidal effects specifically against T. rubrum and T. mentagrophytes 1. The FDA label explicitly lists T. rubrum as an organism against which terbinafine "has been shown to be active...both in vitro and in clinical infections" 2. This is not just theoretical susceptibility—it translates directly to clinical cure.
The majority of T. rubrum isolates globally remain susceptible to terbinafine, with over 60% showing MIC50 and MIC90 < 0.5 µg/mL 3. In China specifically, no non-wild-type (resistant) isolates were observed, with a 97.5% upper limit wild-type MIC of 0.03 mg/L 4. While terbinafine resistance in T. rubrum is emerging (particularly with mutations like Phe397Leu and Leu393Phe), it remains uncommon in most regions 3, 5, 6, 7.
Treatment Recommendation
For your 32-year-old patient, prescribe oral terbinafine 250 mg daily for 12-16 weeks for toenail infection or 6 weeks for fingernail infection 1. This is the gold standard first-line therapy based on superior efficacy compared to all alternatives.
Why Terbinafine is Superior:
- Complete cure rates: 55% at 72 weeks (vs 26% for itraconazole) 1
- Long-term mycological cure: 46% at 5 years (vs 13% for itraconazole) 1
- Lower relapse rates: 23% mycological relapse (vs 53% for itraconazole) 1
- Fungicidal action: Only oral antifungal with direct fungicidal activity against dermatophytes 1
Practical Implementation:
Before starting treatment:
- Check baseline liver function tests and complete blood count if the patient has history of heavy alcohol use, hepatitis, or hematological abnormalities 1
- Avoid in patients with active or chronic liver disease 1
- Review medications metabolized by CYP2D6 1
During treatment:
- Warn about rare but potentially permanent taste disturbance 1
- Common side effects (49%): nausea, diarrhea, taste changes 1
- Dermatological reactions (23%): rash, pruritus, urticaria 1
Follow-up:
- Re-evaluate at 3-6 months after treatment initiation 1
- Continue treatment if disease persists 1
- Terbinafine persists in nails for 6 months after completion, providing ongoing antifungal activity 1
Important Caveats:
While T. rubrum is generally susceptible, if this patient fails oral terbinafine therapy, consider resistance testing 6. Treatment failures occurred in approximately 44% of patients in one U.S. academic center, with some cases confirmed as terbinafine-resistant T. rubrum 6. The emergence of resistance, though still uncommon, underscores the importance of confirming the organism and considering susceptibility testing in treatment failures.
The mechanism of terbinafine action involves inhibiting squalene epoxidase, causing both ergosterol depletion (fungistatic) and toxic squalene accumulation (fungicidal) 1, 2. This dual mechanism explains its superior efficacy against dermatophytes compared to azoles, which only deplete ergosterol.